Background Deep learning offers considerable promise for medical diagnostics. We aimed to evaluate the diagnostic accuracy of deep learning algorithms versus health-care professionals in classifying diseases using medical imaging.
Introduction
The first paper indexed in MEDLINE with the MeSH term "artificial intelligence" (AI) dates back to 1951, when Fletcher described a tortoise robot in the seminal paper "Matter with mind; a neurological research robot". 1 Today, more than 16 000 peer-reviewed scientific papers are published in the AI field each year, with countless more in the lay press. 2 The application of AI has already started to transform daily life through applications such as photo captioning, speech recognition, natural language translation, robotics, and advances in self-driving cars. [3] [4] [5] [6] [7] [8] [9] Many people anticipate similar success in the health sphere, particularly in diagnostics, and some have suggested that AI applications will even replace whole medical disciplines or create new roles for doctors to fulfil, such as "information specialists". [10] [11] [12] Medical imaging is one of the most valuable sources of diagnostic information but is dependent on human interpretation and subject to increasing resource challenges. The need for, and availability of, diagnostic images is rapidly exceeding the capacity of available specialists, particularly in low-income and middle-income countries. 13 Automated diagnosis from medical imaging through AI, especially in the subfield of deep learning, might be able to address this problem. 14, 15 Reports of deep learning models matching or exceeding humans in diagnostic performance has generated considerable excitement, but this enthusiasm should not overrule the need for critical appraisal. Concerns raised in this field include whether some study designs are biased in favour of the new technology, whether the findings are generalisable, whether the study was performed in silico or in a clinical environment, and therefore to what degree the study results are applicable to the real-world setting. More than 30 AI algorithms have now been approved by the US Food and Drug Administration. 16 In anticipation of AI diagnostic tools becoming implemented in clinical practice, it is timely to systematically review the body of evidence supporting AI-based diagnosis across the board.
In this systematic review, we have sought to critically appraise the current state of diagnostic performance by deep learning algorithms for medical imaging compared with health-care professionals, considering issues of study design, reporting, and clinical value to the real world, and we have conducted a meta-analysis to assess the diagnostic accuracy of deep learning algorithms compared with health-care professionals.
Methods

Search strategy and selection criteria
In this systematic review and meta-analysis, we searched for studies that developed or validated a deep learning model for the diagnosis of any disease feature from medical imaging material and histopathology, and additionally compared the accuracy of diagnoses made by algorithms versus health-care professionals. We searched Ovid-MEDLINE, Embase, Science Citation Index, and Conference Proceedings Citation Index for studies published from Jan 1, 2012, to June 6, 2019, with no language restrictions. The full search strategy for each database is available in the appendix (p 2). The cutoff of Jan 1, 2012, was prespecified on the basis of a recognised step-change in machine learning performance with the development of deep learning approaches. In 2012, for the first time, a deep learning model called AlexNet, enabled by advances in parallel computing architectures, made an important breakthrough at the ImageNet Large-Scale Visual Recognition Challenge. 3 The search was first performed on and up to May 31, 2018 , and an updated search was performed on June 6, 2019. Manual searches of bibliographies, citations, and related articles (PubMed function) of included studies were undertaken to identify any additional relevant articles that might have been missed by the searches.
Research in context
Evidence before this study Deep learning is a form of artificial intelligence (AI) that offers considerable promise for improving the accuracy and speed of diagnosis through medical imaging. There is a strong public interest and market forces that are driving the rapid development of such diagnostic technologies. We searched Ovid-MEDLINE, Embase, Science Citation Index, and Conference Proceedings Citation Index for studies published from Jan 1, 2012, to June 6, 2019, that developed or validated a deep learning model for the diagnosis of any disease feature from medical imaging material and histopathology, with no language restrictions. We prespecified the cutoff of Jan 1, 2012, to reflect a recognised change in model performance with the development of deep learning approaches. We found that an increasing number of primary studies are reporting diagnostic accuracy of algorithms to be equivalent or superior when compared with humans; however, there are concerns around bias and generalisability. We found no other systematic reviews comparing performance of AI algorithms with health-care professionals for all diseases. We did find two disease-specific systematic reviews, but these mainly reported algorithm performance alone rather than comparing performance with health-care professionals.
Added value of this study
This review is the first to systematically compare the diagnostic accuracy of all deep learning models against health-care professionals using medical imaging published to date. Only a small number of studies make direct comparisons between deep learning models and health-care professionals, and an even smaller number validate these findings in an out-of-sample external validation. Our exploratory meta-analysis of the small selection of studies validating algorithm and health-care professional performance using out-of-sample external validations found the diagnostic performance of deep learning models to be equivalent to health-care professionals. When comparing performance validated on internal versus external validation, we found that, as expected, internal validation overestimates diagnostic accuracy for both health-care professionals and deep learning algorithms. This finding highlights the need for out-of-sample external validation in all predictive models.
Eligibility assessment was done by two reviewers who screened titles and abstracts of the search results independently, with non-consensus being resolved by a third reviewer. We did not place any limits on the target population, the disease outcome of interest, or the intended context for using the model. For the study reference standard to classify absence or presence of disease, we accepted standard-of-care diagnosis, expert opinion or consensus, and histopathology or laboratory testing. We excluded studies that used medical waveform data graphics material (ie, electroencephalography, electrocardiography, visual field data) or investigated the accuracy of image segmentation rather than disease classification.
Letters, preprints, scientific reports, and narrative reviews were included. Studies based on animals or nonhuman samples or that presented duplicate data were excluded.
This systematic review was done following the recommendations of the PRISMA statement. 17 Methods of analysis and inclusion criteria were specified in advance. The research question was formulated according to previously published recommendations for systematic reviews of prediction models (CHARMS checklist). 18
Data analysis
Two reviewers (XL, then one of LF, SKW, DJF, AK, AB, or TM) extracted data independently using a predefined data extraction sheet, cross-checked the data, and resolved disagreements by discussion or referral to a third reviewer (LMB or AKD). We contacted four authors for further information. [19] [20] [21] [22] One provided numerical data that had only been presented graphically in the published paper and one confirmed an error in their published contingency table. We did not formally assess the quality of the included studies.
Where possible, we extracted binary diagnostic accuracy data and constructed contingency tables at the reported thresholds. Contingency tables consisted of true-positive, false-positive, true-negative, and falsenegative results, and were used to calculate sensitivity and specificity.
To estimate the accuracy of deep learning algorithms and health-care professionals, we did a meta-analysis of studies providing contingency tables from out-ofsample external validations (including geographical and temporally split data). If a study provided various contingency tables for the same or for different algorithms, we assumed these to be independent from each other. We accepted this assumption because we were interested in providing an overview of the results of various studies rather than providing precise point estimates. We used a unified hierarchical model that was developed for the meta-analysis of diagnostic accuracy studies and plotted summary receiver operating characteristic (ROC) curves for the accuracy of health-care professionals and deep learning algorithms. 23 The hierarchical model involves statistical distributions at two different levels. At the lower level, it models the cell counts that form the contingency tables (true positive, true negative, false positive, and false negative) by using binomial distributions. This accounts for the within-study variability. At the higher level, it models the between-study variability (sometimes called heterogeneity) across studies. The hierarchical summary ROC figures provide estimates of average sensitivity and specificity across included studies with a 95% confidence region of the summary operating point and the 95% prediction region, which represents the confidence region for forecasts of sensitivity and specificity in a future study.
Owing to the broad nature of the review-ie, in considering any classification task using imaging for any disease-we were accepting of a large degree of between-study heterogeneity and thus it was not formally assessed. 31 To estimate the accuracy of deep learning algorithms compared with health-care professionals, we did a subanalysis for studies providing contingency tables for both health-care professional and deep learning algorithm performance tested using the same out-ofsample external validation datasets. Additionally, to address the possibility of dependency between different classification tasks done by the same deep learning algorithm or health-care professional within a study, we did a further analysis on the same studies selecting the single contingency table reporting the highest accuracy for each (calculated as proportion of correct classifications).
As an exploratory analysis, we also pooled performances of health-care professionals and deep learning algorithms derived from internally validated test samples. As with the externally validated results, we selected a single contingency table for each study reporting the highest accuracy for health-care professionals and deep learning algorithms. The purpose of this analysis was to explore whether diagnostic accuracy is overestimated in internal validation alone.
Analysis was done using the Stata 14.2 statistics software package. This study is registered with PROSPERO, CRD42018091176.
Role of the funding source
There was no funding source for this study. The lead authors (XL, LF) had full access to all the data in the study and had final responsibility for the decision to submit for publication.
Results
Our search identified 31 587 records, of which 20 530 were screened (figure 1). 122 full-text articles were assessed for eligibility and 82 studies were included in the systematic review. [19] [20] [21] [22] These studies described 147 patient cohorts and considered ophthalmic disease (18 studies), breast cancer (ten studies), trauma and orthopaedics (ten studies), dermatological cancer (nine studies), lung cancer (seven studies), respiratory disease (eight studies), gastroenterological or hepatological cancers (five studies), thyroid cancer (four studies), gastroenterology and hepatology (two studies), cardiology (two studies), oral cancer (two studies), nephrology (one study), neurology (one study), maxillo facial surgery (one study), rheumatology (one study), nasopharyngeal cancer (one study), and urological disease (one study; table 1). One study included two different target conditions. 58 Study characteristics are summarised in the tables (tables 1, 2, 3). 72 studies used retrospectively collected data and ten used prospectively collected data (table 3) . 25 studies used data from open-access repositories. No studies reported a prespecified sample size calculation. 26 studies reported that low-quality images were excluded, 18 did not exclude low-quality images, and 38 did not report this. Four studies 19, 42, 51, 80 also tested the scenario where health-care professionals are given additional clinical information alongside the image, and one study 19 tested single image versus the addition of historical images for both health-care professionals and the deep learning algorithm. Four studies also considered diagnostic performance in an algorithmplus-clinician scenario. 69, 74, 85, 87 Reference standards were wide ranging in line with variation of the target condition and the modality of imaging being used, with some studies adopting multiple methods (table 2) . 38 studies used histopathology; 28 studies used varying models of expert consensus; one study relied on single expert consensus; nine studies used clinical follow-up; two studies used surgical confirmation; three studies used reading centre labels (such as when clinical trial data were used); eight studies used existing clinical care notes or imaging reports or existing labels associated with open data sources. Four studies used another imaging modality to confirm the diagnosis and three studies used laboratory testing.
69 studies provided sufficient information to enable calculation of contingency tables and calculation of test performance parameters, with a total of 595 tables across these studies. Within this group, sensitivity for deep learning models ranged from 9·7% to 100·0% (mean 79·1%, SD 0·2) and specificity ranged from 38·9% to 100·0% (mean 88·3%, SD 0·1).
Of the 69 studies, 25 studies did an out-of-sample external validation and were therefore included in a meta-analysis. 21, 28, 30, 34, [36] [37] [38] [39] 43, [53] [54] [55] [56] 61, [65] [66] [67] 70, 73, 74, 79, 81, 90, 91, 99 In line with the aims of this review, all eligible studies were included regardless of the target condition. The meta-analysis therefore included diagnostic classifications in multiple specialty areas, including ophthalmology (six studies), breast cancer (three studies), lung cancer (two studies), dermatological cancer (three studies), trauma and orthopaedics (two studies), respiratory disease (two studies), Hierarchical summary ROC curves of these 25 studies (161 contingency tables) are shown in figure 2 . When averaging across studies, the pooled sensitivity was 88·6% (95% CI 85·7-90·9) for all deep learning algorithms and 79·4% (74·9-83·2) for all health-care professionals. The pooled specificity was 93·9% (92·2-95·3) for deep learning algorithms and 88·1% (82·8-91·9) for health-care professionals.
Of these 25 studies, only 14 used the same sample for the out-of-sample validation to compare performance between deep learning algorithms and health-care professionals, with 31 contingency tables for deep learning algorithm performance and 54 tables for healthcare professionals ( figure 3 ). The pooled sensitivity was 85·7% (95% CI 78·6-90·7) for deep learning algorithms and 79·4% (74·9-83·2) for health-care professionals. The pooled specificity was 93·5% (89·5-96·1) for deep learning algorithms and 87·5% (81·8-91·6) for healthcare professionals.
After selecting the contingency table reporting the highest accuracy for each of these 14 studies (ie, 14 tables for deep learning algorithms and 14 tables for health-care professionals), the pooled sensitivity was 87·0% (95% CI 83·0-90·2) for deep learning algorithms and 86·4% (79·9-91·0) for health-care professionals. The pooled specificity was 92·5% (85·1-96·4) for deep learning algorithms and 90·5% (80·6-95·7) for healthcare professionals ( figure 4) .
As an exploratory analysis, we also pooled performances of health-care professional and deep learning algorithms derived from matched internally validated samples (37 studies). Again, we selected a single contingency table for each study reporting the highest accuracy. In this sample, all accuracy metrics were higher, with a pooled sensitivity of 90·1% (95% CI 86·9-92·6) for deep learning algorithms and 90·5% (86·3-93·5) for healthcare professionals and a pooled specificity of 93·3% (90·1-95·6) for deep learning algorithms and 91·9% (87·8-94·7) for health-care professionals ( figure 4 ).
Discussion
To our knowledge, this is the first systematic review and meta-analysis on the diagnostic accuracy of health-care professionals versus deep learning algorithms using medical imaging. After careful selection of studies with transparent reporting of diagnostic performance and validation of the algorithm in an out-of-sample population, we found deep learning algorithms to have equivalent sensitivity and specificity to health-care professionals. Although this estimate seems to support the claim that deep learning algorithms can match clinician-level accuracy, several methodological deficiencies that were common across most included studies should be considered.
First, most studies took the approach of assessing deep learning diagnostic accuracy in isolation, in a way that does not reflect clinical practice. Many studies were excluded at screening because they did not provide comparisons with health-care professionals (ie, human vs machine), and very few of the included studies reported comparisons with health-care professionals using the same test dataset. Considering deep learning algorithms in this isolated manner limits our ability to extrapolate the findings to health-care delivery, except perhaps for mass screening. 102 Only four studies provided health-care professionals with additional clinical information, as they would have in clinical practice; one study also tested the scenario in which prior or historical imaging was provided to the algorithm and the health-care professional, and four studies also considered diagnostic performance in an algorithm-plus-clinician scenario. It is worth noting that no studies reported a formal sample size calculation to ensure that the study was sufficiently sized in a headto-head comparison. Although we acknowledge that sample size calculations can be challenging in this context, a lack of consensus on principled methods to perform them is no justification to ignore them in the design of a study. Second, there were very few prospective studies done in real clinical environments. Most studies were retrospective, in silico, and based on previously assembled datasets. The ground truth labels were mostly derived from data collected for other purposes, such as in retrospectively collected routine clinical care notes or radiology or histology reports, and the criteria for the presence or absence of disease were often poorly defined. The reporting around handling of missing information in these datasets was also poor across all studies. Most did not report whether any data were missing, what proportion this represented and how missing data were dealt with in the analysis. Such studies should be considered as hypothesis generating, with real accuracy defined in patients, not just datasets.
Third, a wide range of metrics were employed to report diagnostic performance in deep learning studies. If a probability function is not reported, the frequency of true positives, false positives, false negatives, and true negatives at a specified threshold should be the minimum requirement for such comparisons. In our review, only 12 studies reported the threshold at which sensitivity and specificity were reported, without justification of how the threshold was chosen; choice of threshold is often set at the arbitrary value of 0·5, as is convention in machine learning development. Metrics commonly used in the field of computer science, such as accuracy, precision, dice coefficient, and F1 score, are sometimes the only measure for reporting diagnostic performance. Since these tests are usually performed at a prevalence of 50%, these parameters are less comprehensive and useful for clinical practice.
Fourth, there is inconsistency over key terminology used in deep learning studies. Distinct datasets with independent samples should be defined in the development of a deep learning model from the initial training set through to one or more test sets that support validation. We found that the term "validation" is used variably, with some authors using the term appropriately for testing of the final model but others using it for the tuning of a model during development. It is crucial that the validation test set contains data independent to training or tuning data and is used only for assessing the final model. In several studies, we found a lack of transparency as to whether the test set was truly independent due to this inconsistent use of terminology. A standard nomenclature should be adopted. We suggest distinguishing the datasets involved in the development of an algorithm as training set (for training the algorithm), tuning set (for tuning hyperparameters), and validation test set (for estimating the performance of the algorithm). For describing the different types of validation test sets, we suggest adoption of the suggestion by Altman and Royston: internal validation (for in-sample validation), temporal validation (for in-sample validation with a temporal split), and external validation (for out-of sample validation). 103 Finally, although most studies did undertake an outof-sample validation, most did not do this for both health-care professionals and deep learning algorithms. Moreover, only a small number of studies tested the performance of health-care professionals and deep learning algorithms in the same sample. In this review, we accepted both geographically and temporally split 
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Figure 4: Hierarchical ROC curves of studies restricted to contingency tables reporting the highest accuracy
Hierarchical ROC curves are shown for the 14 studies using the same out-of-sample validation sample to compare performance between deep learning algorithms and health-care professionals (A) and the 37 studies using matched internally validated samples (B). In both analyses, the single contingency table reporting the highest accuracy for each study was included. ROC=receiver operating characteristic.
test data, as well as the use of open-access datasets, as external validations. For internal validation, most studies adopted the approach of randomly splitting a single sample into training, tuning, and test sets, instead of preferred approaches such as resampling methods (eg, bootstrapping and cross validation), which have been recommended in clinical prediction model guidelines. 18 Our finding when comparing performance on internal versus external validation was that, as expected, internal validation overestimates diagnostic accuracy in both health-care professionals and deep learning algorithms. This finding highlights the need for out-of-sample external validation in all predictive models.
An encouraging finding of this review is the improvement in quality of studies within the last year. 58 (71%) of the 82 studies satisfying the inclusion criteria were newly identified in the updated search, suggesting that the past year has seen a substantial increase in the number of studies comparing algorithm accuracy with health-care professionals. Only five studies additionally did external validation for algorithms and health-care professionals and were eligible for meta-analysis before the updated search, whereas a further 20 studies were suitable for meta-analysis in the review update. A persistent problem is studies not reporting contingency tables (or of sufficient detail for construction of contingency tables), as we were unable to construct contingency tables for two (9%) of 22 studies in the original search and 11 (18%) of 60 studies in the updated search.
Our final comparison estimating the differences in diagnostic accuracy performance between deep learning algorithms and health-care professionals is based on a relatively small number of studies. Less than a third of the included studies were eligible for meta-analysis. This is a direct consequence of poor reporting and lack of external validation in many studies, which has resulted in inadequate data availability and thus exclusion from the meta-analysis. We acknowledge that inadequate reporting does not necessarily mean that the study itself was poorly designed and, equally, that poor study design does not necessarily mean that the deep learning algorithm is of poor quality. Accordingly, there is considerable uncertainty around the estimates of diagnostic perfor mance provided in our exploratory meta-analysis and we must emphasise that reliable estimates of the level of performance can only be achieved through well designed and well executed studies that minimise bias and are thoroughly and transparently reported.
We have not provided a systematic quality assessment for transparency of reporting in this review. This decision was made because existing reporting guidelines for prediction models, such as the Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD) statement, are focused primarily on regression-based model approaches, and there is insufficient guidance on how to appropriately apply its checklist items to machine learning prediction models. The issues we have identified regarding nonstandardisation of reporting in deep learning research are increasingly becoming recognised as a barrier to robust evaluation of AI-based models. A step in the right direction was the Delphi process undertaken by Luo and colleagues 104 to generate guidelines for developing and reporting machine learning predictive models. However, these guidelines have not been widely adopted, nor are they currently mandated by journals. An initiative to develop a machine learning version of the TRIPOD statement (TRIPOD-ML) was announced in April, 2019. 105 Although most of the issues we have highlighted are avoidable with robust design and high-quality reporting, there are several challenges that arise in evaluating deep learning models that are specific to this field. The scale of data required for deep learning is a well recognised challenge. What is perhaps less recognised is the way that this requirement skews the types of data sources used in AI studies, and the relative paucity of some of the associated data. For example, in many studies, historical registry data collected from routine clinical care or opensource databases are used to supply sufficient input data. These image repositories are rarely quality controlled for the images or their accompanying labels, rendering the deep learning model vulnerable to mistakes and unidentified biases. Population characteristics for these large datasets are often not available (either due to not being collected, or due to issues of accessibility), limiting the inferences that can be made regarding generalisability to other popu lations and introducing the possibility of bias towards particular demographics.
Traditionally, heavy emphasis for developing and validating predictive models is on reporting all covariates and model-building procedures, to ensure transparent and reproducible, clinically useful tools. 106 There are two main reasons why this is not possible in deep learning models in medical imaging. First, given the high dimensionality of the images, there are often too many individual datapoints driving predictions to identify specific covariates. Second, this level of influence and transparency of the algorithm is fundamentally incompatible with the black box nature of deep learning, where the algorithm's decisions cannot be inspected or explained. Few methods for seeing inside the black boxthe black box deconvolution-are available, but new methods are being actively explored. An important example is the use of saliency or heat maps, which many studies adopt to provide some qualitative assessment of predictive features within the image. 20, 28, 45, 46, 58, 107 Other recent approaches such as influence functions and segmentation can offer additional information alongside saliency or heat maps. 42, 108 However, these approaches remain crude as they are limited to highlighting the location of salient features, rather than defining the pathological characteristics themselves, which would then allow a reproducible model to be built. Due to the inability to interrogate a deep learning model, some caution should be exercised when making assumptions on a model's generalisability. For example, an algorithm could incorrectly form associations with confounding non-pathological features in an image (such as imaging device, acquisition protocol, or hospital label) simply due to differences in disease prevalence in relation to those parameters. 109, 110 Another consideration is the transparency of reporting deep learning model building procedures. These studies often do not report the full set of hyperparameters used, meaning the model cannot be reproduced by others. There are also issues of underlying infrastructure that pose similar challenges. For example, those building the AI model might use custom-built or expensive infrastructure that is simply not available to most research groups, and thus present concerns around reproducibility and the ability to scrutinise claims made in peer review. Cloud-based development environments can support code sharing between researchers without compromising proprietary information, but more work is needed to establish gold standards in reporting results in this domain.
Any diagnostic test should be evaluated in the context of its intended clinical pathway. This is especially important with algorithms where the model procedures and covariates cannot be presented explicitly. A randomised head-to-head comparison to an alternative diagnostic test, in the context of a clinical trial, could reveal and quantify possible clinical implications of implementing an algorithm in real life. Moreover, a common problem of test evaluation research could be overcome by testing these algorithms within a clinical trial: classification tasks are typically assessed in isolation of other clinical information that is commonly available in the diagnostic work-up. 111 Prospective evaluations of diagnostic tests as complex interventions would not only reveal the impact of these algorithms upon diagnostic yield but also on therapeutic yield. 112 In this context, the reporting of AI and machine learning interventional trials warrant additional consideration, such as how the algorithm is implemented and its downstream effects on the clinical pathway. In anticipation of prospective trials being the next step, extensions to the Consolidated Standards of Reporting Trials and Standard Protocol Items: Recommendations for Interventional Trials reporting guidelines for clinical trials involving AI interventions are under development. [113] [114] [115] Diagnosis of disease using deep learning algorithms holds enormous potential. From this exploratory metaanalysis, we cautiously state that the accuracy of deep learning algorithms is equivalent to health-care professionals, while acknowledging that more studies considering the integration of such algorithms in realworld settings are needed. The more important finding around metho dology and reporting means the credibility and path to impact of such diagnostic algorithms might be undermined by an excessive claim from a poorly designed or inadequately reported study. In this review, we have highlighted key issues of design and reporting that investigators should consider. These issues are pertinent for ensuring studies of deep learning diagnostics-or any other form of machine learning-are of sufficient quality to evaluate the performance of these algorithms in a way that can benefit patients and health systems in clinical practice.
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